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Cognitive impairmentSigniﬁcant corpus callosum (CC) involvement has been found in relapsing–remitting multiple sclerosis (RRMS),
even if conventional magnetic resonance imaging measures have shown poor correlation with clinical disability
measures. In this work, we tested the potential of multimodal imaging of the entire CC to explain physical and
cognitive disability in 47 patients with RRMS. Values of thickness, fractional anisotropy (FA) andmean diffusivity
(MD) were extracted from 50 regions of interest (ROIs) sampled along the bundle. The relationships between
clinical, neuropsychological and imaging variables were assessed by using Spearman3s correlation. Multiple lin-
ear regression analysiswas employed in order to identify the relative importance of imagingmetrics inmodeling
different clinical variables. Regional ﬁber composition of the CC differentially explained the response variables
(ExpandedDisability Status Scale [EDSS], cognitive impairment). Increases in EDSSwere explained by reductions
in CC thickness andMD. Cognitive impairment wasmainly explained by FA reductions in the genu and splenium.
Regional CC imaging properties differentially explained disability within RRMS patients revealing strong, distinct
patterns of correlation with clinical and cognitive status of patients affected by this speciﬁc clinical phenotype.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Multiple sclerosis (MS) is a complex and clinically heterogeneous in-
ﬂammatory demyelinating disease of the central nervous system that
often results in marked physical and cognitive impairment. During the
course of the disease, the tissue of the entire central nervous system is
affected by demyelination, axonal damage, gliosis, inﬂammation and,
sometimes, remyelination, which cannot be clearly distinguished
in vivo by conventional MRI (Schmierer et al., 2007). The corpus
callosum (CC) is the largest white matter bundle in the human brain
and has been found affected by lesions in up to 53% of MS patients
(Barnard and Triggs, 1974; Gean-Marton et al., 1991; Lumsden, 1971;
Simon et al., 1986). Given its size and the strong directionality of its ﬁ-
bers, CC is one of the few white matter tracts that can be identiﬁed
with low uncertainty by quantitative MRI and diffusion tensor imagingagna Graecia”, Viale Europa,
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. This is an open access article under(DTI), which allow the study of its macro- and microstructures respec-
tively. Although it is well known that CC damage progresses along the
course of MS (Pelletier et al., 2001), studies on the correlation between
bundle abnormalities and disability have led to inconsistent results
(Hasan et al., 2005; Sigal et al., 2012; Rimkus et al., 2013; Ozturk et al.,
2010; Yaldizli et al., 2014). To our knowledge, the majority of these
studies adopted metrics averaged on a priori subdivisions of the CC to
investigate its involvement in MS. Given the limited correlation previ-
ously found betweenMRImeasures of the CC and physical and cognitive
disability, we hypothesized that a stronger relationship could be uncov-
ered by analyzing region-speciﬁc callosal changes, detected by multi-
modal MRI. Our assumption was that, without any a priori constraint
upon the topography of the bundle, macro- andmicro-structural abnor-
malities might yield complementary information about disability in a
cohort of patients with a relapsing–remitting course of MS (RRMS).
2. Materials and methods
2.1. Patients
Forty-seven consecutive patients with a diagnosis of RRMS accord-
ing to the 2010 revisedMcDonald criteria (Polman et al., 2011)were in-
volved in this study. Inclusion criteria were absence of clinical relapsesthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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modifying therapy (Interferon-beta or Glatiramer acetate). Since mech-
anisms bywhich disease-modifying agents may act on the brain are not
fully understood (Zivadinov et al., 2008), we chose to homogenize our
sample in terms of immuno-modulating therapy, to exclude confound-
ing effects onMRImeasures that could be triggered bymedications and
not only by MS pathology. Other exclusion criteria were: evidence
ofmajor depression or other psychiatric disorders; past or current histo-
ry of traumatic brain injury or other coexisting medical disorders; con-
sumption of antidepressant, anxiolytic, antipsychotic or antiepileptic
drugs; and consumption of steroids in the month before the neuropsy-
chological testing, since these substances may inﬂuence cognitive per-
formance. On the same day of the MRI acquisition, in all participants
physical disability was assessed by the Expanded Disability Status
Scale (EDSS) score while cognitive and executive functions were ex-
plored through the Brief Repeatable Battery of Neuropsychological
Tests and the Stroop test, administered by an expert (C.C.) with more
than 10 years of experience in MS. The following domains were ex-
plored: a) verbal memory: Long Term Storage, Consistent Long Term
Recall, and Selective Reminding Test Delayed; b) language: Word List
Generation; c) visuo-spatial memory: Spatial Recall Test (Immediate
and Delayed); and d) executive functions: Symbol Digit Modalities
Test and Stroop Test. Cut-off values for each test were extracted by pre-
viously published normative data on the Italian population (Amato
et al., 2006). In order to deﬁne the degree of neuropsychological impair-
ment, an overall cognitive score was determined for each patient as the
number of failed tests.
All participants provided written informed consent and the study
was approved by the institutional review board.
2.2. MRI acquisition and processing
All participants underwent the sameMRI scanning protocol. Patients
were examined using a 3-Tesla GEMR750 scanner (GE Healthcare, Rah-
way, NJ). The MRI protocol included whole-brain, three-dimensional,
T1-weighted (BRAVO), spoiled gradient recall echo (TE/TR = 3.7/
9.2 ms, ﬂip angle 12°, voxel size = 1 × 1 × 1 mm3); DTI (b = 0, 1000;
diffusion weighting along 27 non-collinear gradient directions; matrix
size 128 × 128; 80 axial slice; number of b0 images = 4; NEX = 2;
voxel size = 2 × 2 × 2 mm3); and fast ﬂuid-attenuated inversion-
recovery (FLAIR) axial images (TR = 9500 ms, TE = 100 ms; matrix
size 512 × 512, FOV: 24 cm; 36 slices, 4 mm slices, 0 mm gap). Image
processing was performed using the Functional Magnetic Resonance
Imaging of the Brain (FMRIB) Analysis Group Software Library (FSL)
(Oxford University, United Kingdom). Image distortions induced by
eddy currents and headmotion in theDTI datawere corrected by apply-
ing a 3D full afﬁne (mutual information cost function) alignment of each
image to the mean no diffusion weighting (b0) image. After distortion
corrections, DTI data were averaged and concatenated into twenty-
eight (1 mean b0 + 27 b1000) volumes. A diffusion tensor model was
ﬁt at each voxel, generating fractional anisotropy (FA) andmean diffusiv-
ity (MD) maps. The FA maps created were then registered to brain-
extracted whole-brain volumes from T1-weighted images using a full
afﬁne (correlation ratio cost function) alignment with nearest-neighbor
resampling. The calculated transformation matrix was then applied to
the MD maps with identical resampling options. Normal appearing CC
wasmanually segmented by two experts (P.P. and A.G.) on themidsagit-
tal plane of T1-weighted images, and subsequently averaged on a consen-
sus binary mask. To accurately and automatically extract the bundle
thickness proﬁle we used an approach recently proposed by Adamson
et al. (2011). Brieﬂy, the thickness model was derived by computing a
solution to Laplace3s equation evaluated on callosal voxels. The stream-
lines from this solution formed non-overlapping, cross-sectional con-
tours, the lengths of which were modeled as the callosal thickness. A
smooth center line, obtained with cubic spline interpolation between
measurement points, was divided into 51 regions of interest (ROIs) ofequal lengths by 50 nodes. At each node, the distance of the line extend-
ing orthogonally to each boundary of the CC represented its thickness.
We then extracted the values of MD and FA from the same 50 ROIs by
overlaying the thickness proﬁle onto the T1-coregistered DTI maps.
At each ROI, we computed the MD/FA value as a weighted 2D Gaussian
average with radius 2 mm. Manual delineation of T1 and FLAIR lesions
was performed by an expert radiologist (P.P.), who traced the lesion
outline with a mouse-controlled cursor by using MRIcron software
(http://www.mccauslandcenter.sc.edu/CRNL). Lesion volume across
whole brain, whole CC and midsagittal CC was assessed by using FSL. A
graphical description of the processing workﬂow is shown in Fig. 1.
2.3. Statistical analysis
Spearman3s correlation was tested between each of the clinical/
neuropsychological variables and, in turn, each of the three imaging
features from the entire CC (i.e., thickness, FA,MD). Spearman3s correla-
tion was used since Shapiro–Wilk testing showed that our variables
were not normally distributed. Correlation signiﬁcance level was set
at P = 0.05 after correcting for multiple comparisons according to the
false discovery rate method (Benjamini and Hochberg, 1995). In order
to understand which of the three imaging variables had a greater role
in explaining clinical and cognitive status in RRMS, we performed a
multivariate linear regression analysis. For each ROI of the CC, we built
three different linear regression models in which thickness, MD and
FA of the ROI were explanatory variables and EDSS, disease duration
and cognitive performance, in turn, represented the dependent vari-
able. Also, gender was added to the model as a covariate, since it has
been shown to have an effect on disease progression (Voskuhl and
Gold, 2012). In eachmodel (i.e., on each ROI of the bundle)we identiﬁed
the explanatory variable that better described the response variable by
comparing the regression coefﬁcients. To take into account the inﬂu-
ence of MS lesions, regression analyses were repeated adding lesion
load (either total or regional) in each model as the fourth explanatory
variable. Since we analyzed the entire bundle, we used the Witelson
scheme as a guide to interpret results (Witelson, 1989). The topography
of the CC is described by ﬁve sections, deﬁned as arithmetic fractions of
the maximum anterior–posterior extent. Section I, including the ros-
trum, genu, and rostral body, is crossed by ﬁbers from the prefrontal,
premotor, and supplementary motor cortical areas. Motor ﬁbers are
assumed to cross the CC through the anterior midbody (section II),
whereas the somaesthetic and posterior parietal ﬁber bundles should
cross the CC through the posterior midbody (section III). The isthmus
(section IV) is assigned to the posterior parietal and superior temporal
cortical areas, and the splenium (section V), is assigned to the inferior
temporal, parietal, and occipital cortical regions.
3. Results
3.1. Study cohort
Demographic and clinical characteristics of the cohort are shown in
Table 1. Thirteen patients (27.7%) failed at least three out of nine neuro-
psychological tests and were considered cognitively impaired.
3.2. Correlation analysis between clinical and neuropsychological variables
and structural and diffusion properties of the CC
As shown in Fig. 2, correlation between EDSS and thickness was
largely signiﬁcant in the anterior midbody (section II, r values ranging
from−0.50 to −0.63, P b 0.05). The signiﬁcance pattern for MD and
FA showed signiﬁcant correlation in the splenium (section V; MD
only: r values ranging from 0.42 to 0.44, P b 0.05), in section II (FA: r
values ranging from −0.46 to −0.49, P b 0.05; MD: r values ranging
from 0.49 to 0.59, P b 0.05) and in section I (FA: r values ranging from
−0.38 to −0.45, P b 0.05; MD: r values ranging from 0.52 to 0.59,
Fig. 1. Image processingworkﬂow. FLAIR: ﬂuid attenuated inversion recovery; DTI: diffusion tensor imaging; NAWM: normal-appearingwhitematter; CC: corpus callosum; FA: fractional
anisotropy; MD: mean diffusivity.
Table 1
Demographic, clinical and neuropsychological characteristics of the cohort.
Subjects, n 47
Course of disease RRMS
Median age, y (range) 34 (21–61)
Female, % 60
Age at onset, y (SD) 27.5 (7.2)
Disease duration, mo (SD) 97.7 (80.9)
Education, y (SD) 11.6 (3.2)
Median EDSS score (IQR) 2.0 (2.0–4.0)
DMT IFN-B/GLAT
Whole-brain lesion volume, mm3 (SD) 17,851.2 (14,917.9)
Mean MMSE (SD) 29.0 (1.4)
LTS; mean (SD) 37.1 (13.5)
CLTR; mean (SD) 27.1 (11.8)
SRTD; mean (SD) 6.3 (2.5)
SPART-I; mean (SD) 17.5 (4.9)
SPART-D; mean (SD) 5.8 (2.4)
WLG; mean (SD) 16.0 (4.2)
SDMT; mean (SD) 38.1 (12.2)
STROOP-C; mean (SD) 37.8 (9.5)
STROOP-CW; mean (SD) 18.7 (6.0)
Cognitive score, median number of failed tests (range) 2 (0–7)
Abbreviations: RRMS= relapsing–remitting multiple sclerosis; SD= standard deviation;
EDSS = Expanded Disability Status Scale; DMT = Disease Modifying Therapy; IFN-B/
GLAT = Interferon-beta/Glatiramer acetate; MMSE = Mini Mental State Examination;
LTS = Long Term Storage; CLTR = Consistent Long Term Recall; SRTD = Selective
Reminding Test Delayed; SPART-I=Spatial Recall Test Immediate; SPART-D=Spatial Re-
call Test Delayed; WLG =Word List Generation; SDMT= Symbol Digit Modalities Test;
STROOP-C = Stroop Color Task; STROOP-CW= Stroop Color–Word Task; IQR = inter-
quartile range.
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along the bundle thickness proﬁle: we found that correlation was most
signiﬁcant across section III (r values ranging from −0.39 to −0.49,
P b 0.05) and sections IV−V (r values ranging from −0.38 to −0.46,
P b 0.05), while barely signiﬁcant in section I (r values ranging from
−0.38 to−0.39, P b 0.05), according toWitelson3s classiﬁcation. Corre-
lation signiﬁcance between duration and MD was not signiﬁcant. In-
stead, correlation with FA was signiﬁcant in section I (r values ranging
from −0.36 to −0.44, P b 0.05) and section V (r = −0.38, P b 0.05).
The cognitive score correlated with all the imaging variables along the
whole bundle, revealing peaks of signiﬁcant correlation with thickness
in section I (r values ranging from −0.46 to −0.59, P values b 0.05),
with FA in sections I and IV (I: r values ranging from−0.46 to−0.55,
P b 0.05; IV: r values ranging from−0.44 to−0.55, P b 0.05) and with
MD across sections III and IV (III: r values ranging from 0.46 to 0.51,
P b 0.05; IV: r values ranging from 0.42 to 0.52, P b 0.05) and in section
I (r values ranging from 0.43 to 0.50, P b 0.05).3.3. Regression analysis
As shown in Fig. 3, multivariate linear regression analysis conﬁrmed
the spatially heterogeneous relationship between key variables of RRMS
disability and multimodal imaging characteristics of the entire CC. In
particular, when considering only thickness,MD, and FA as independent
variables, relationshipwith EDSS in sections II and IVwasmainly guided
by thickness, whileMD gave signiﬁcant contributions tomodel variance
Fig. 2. Signiﬁcance of Spearman3s correlation between the threemain disease variables (EDSS, disease duration, cognitive score) and each of the imagingmetrics (thickness, FA, MD)mea-
sured along the entire CC; on the color map, green corresponds to the signiﬁcance threshold P = 0.05, corrected for multiple comparisons with false discovery rate approach.
31M.E. Caligiuri et al. / NeuroImage: Clinical 7 (2015) 28–33in sections I and III. FA contributions were barely present only in region
I. Relationship between the bundle and disease duration highlighted a
signiﬁcant contribution from thickness in sections II and IV, from MD
in the splenium and from FA in the anterior third. When modeling cog-
nitive score, instead, FA contributed consistently in section I and to a less
extent in region IV, combined with MD in sections III and V, and with
thickness in the rostrum. We repeated the analysis by adding lesion
volume as explanatory variable. We used lesion volume both in whole
white matter and in a callosal ROI centered on the midsagittal CC
section: since results were very similar, we reported only those relative
to the whole-brain lesion load. By including lesion volume in the
analysis, the relative importance of the independent variables in
explaining the variance of each model remained roughly unchangedFig. 3. Regression coefﬁcients of the imaging variables acting as predictors in the multivariate a
highlight post-hoc correspondence between each predictor3s contribution in explaining the clinand, as expected, the insertion of lesion load increased the overall vari-
ance explained by the models.
4. Discussion
In the present study, we have analyzed microstructural abnormali-
ties across the entire CC in RRMS patients. To the best of our knowledge,
this is the ﬁrst study correlating callosal ﬁber thickness, MD and FA in
different CC ROIs with disability. In contrast to the majority of studies,
we carried out the analysis without imposing any a priori subdivision on
the bundle. Astonishingly, the ROIs signiﬁcantly involved in explaining
disability were naturally matched to the functional sections described
by Witelson (1989) and to the ﬁber composition of the bundle observednalysis. A graphical representation of the Witelson classiﬁcation is shown on the x-axis to
ical response variable and the different ﬁber classes of the bundle.
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hoc interpretation of results. In particular, associations between physical
and cognitive disability and structural abnormalitieswere spatially segre-
gated. Previous studies had discovered progressive damage of the CC in
MS patients compared to controls (Pelletier et al., 2001), but ﬁndings
about the relationship between the bundle and disease variables have
been rather inconsistent, ranging from no relationship at all (Hasan
et al., 2005) to modest associations (Sigal et al., 2012; Rimkus et al.,
2013) mainly with interhemispheric dysfunction measures rather than
clinical disability variables (Pelletier et al., 2001; Ozturk et al., 2010;
Yaldizli et al., 2014), or among different disease courses (Pelletier et al.,
2001; Hasan et al., 2005; Sigal et al., 2012; Rimkus et al., 2013; Ozturk
et al., 2010; Yaldizli et al., 2014). Furthermore, to our knowledge, none
had yet modeled clinical variables through continuous imaging features
within RRMS only. We believe that, in this framework, it is possible to
study the speciﬁc disease course without the inﬂuence of those mecha-
nisms that promote progression to other courses.
4.1. Correlation ﬁndings
Disease duration was associated with bundle thickness, which is in
line with different other studies conﬁrming that atrophy progresses
along the course of the disease (Pelletier et al., 2001). As expected,
EDSS score, which measures physical disability, correlated with regions
of the bundle crossed bymotor andpremotorﬁbers. The cognitive score,
on the other hand, correlated with CC properties of those ROIs crossed
by ﬁbers from the prefrontal, temporal and parietal cortical areas,
which are all interconnected in order to exploit higher-level brain func-
tions. We believe that the highly signiﬁcant correlations, discrepant
with respect to previous research (Hasan et al., 2005; Sigal et al.,
2012; Rimkus et al., 2013), might be largely explained by the fact that
we assessed CC damage in a continuous fashion, without recurring to
a priori subdivisions, and consequently to metrics averaged over pre-
determined sections, which might have led to loss of space-variant
information.
4.2. Regression ﬁndings
Multiple regression analyses uncovered the differential pattern of
contributions from the imaging characteristics of the entire CC to the
global measures of disease severity. Disease duration was mainly ex-
plained by reductions in bundle thickness over the sections crossed by
sensorimotor and temporo-parietal ﬁbers, by MD increases in regions
corresponding to occipital ﬁbers and by FA decreases in prefrontal
ﬁbers. It is known from the literature (Aboitiz et al., 1992) that small
ﬁbers are densely distributed in the genu and to some extent in the
splenium, while large myelinated ﬁbers are mainly found in the body.
In the light of this, the signiﬁcant contribution to the model of disease
duration carried by MD and FA rather than thickness of prefrontal and
occipital ﬁbers could be interpreted as an early marker of ﬁber damage
that has not yet resulted in macroscopic atrophy, due to the large num-
ber of ﬁberswith a small diameter that populate those regions of the CC.
On the contrary, atrophy was more evident where there was loss of
large, heavily myelinated axons (motor ﬁbers). Regression models of
EDSS showed that thickness reductions in the splenium and in motor
areas, together with MD increases in the prefrontal and sensory areas,
gave themost signiﬁcant contributions to themodel of physical disabil-
ity. As shown in Fig. 3, by comparing the models of duration and phys-
ical disability, it can be seen that the beta coefﬁcients relative to disease
duration assume smaller values. This is in line with the evidence that
there is no direct correspondence between disease duration and disease
severity (Fisniku et al., 2008). Finally, whenmodeling cognitive impair-
ment, FA gave themost consistent contribution to the analysis in the re-
gions crossed by prefrontal and temporal ﬁbers, thus suggesting
damage of ﬁbers involved in executive function and memory circuits,while MD contributed in sections related to somatosensory and occipi-
tal ﬁbers.
4.3. Possible application in clinical trials
Since trials of potential neuroreparative agents are increasingly im-
portant in the spectrum of MS research, the need for appropriate imag-
ing markers has been recently pointed out (Mallik et al., 2014). These
measures should be computationally lean to obtain from MR images,
should be sensitive and speciﬁc to myelin and, of course, should be re-
producible and clinically meaningful. In this context, we believe that
the present analysismethod could be a convenientMRImarker in a clin-
ical trial, from several points of view. First, it is computationally lean and
reproducible: in fact, although in this testing phase it has been applied
on manual segmentation of the CC, the entire analysis can be easily
automated (Adamson et al., 2014). Second, our results are coherent
and show meaningful clinical relationships. Third, DTI metrics ex-
tracted continuously from the CC might indirectly bring information
on demyelination/remyelination. Despite the well-known limita-
tions of diffusion-tensormodeling, these affect the DTImetrics main-
ly when ﬁber orientation per voxel cannot be correctly estimated,
which should not be frequent when dealing with highly directional
structures like the CC. Even taking into account DTI pitfalls, novel
methods for a better reconstruction of ﬁber orientation are currently
being implemented and could be easily integrated in our analysis
(for a comparison of most recently developed methods see Daducci
et al., 2014). Last, but not least, we believe that the CC might represent
a crucial structure for monitoring the effects of neuroreparative
drugs because of the varied nature of the ﬁbers that form it. Damage
or repair to its different regions, as measured with this convenient
marker, might bring further insights not only on the integrity of
callosal ﬁbers, but also, indirectly, on the status of cortical regions
that these ﬁbers connect.
For all these reasons and from a wider perspective, continuous
measures of callosal macro- and micro-structural integrity could
be adopted to monitor drug efﬁcacy in clinical trials focusing on
neurorepair in multiple sclerosis, thus improving the treatment of
disability and, as a consequence, the quality of life of patients suf-
fering from this disease.
4.4. Limitations
Although the present study displays coherent relationships it has
some limitations: ﬁrst, the sample size is relatively small, especially
given the heterogeneity of the disease. Second, results should be con-
ﬁrmed by longitudinal data. For this reason future studies should fore-
see a follow-up stage on a larger cohort of patients. Our efforts will
thus focus on the progression of damage along the individual disease
course, which is especially relevant when designing new treatment
strategies.
5. Conclusion
In thiswork,we demonstrated the ability ofmultimodalMRImetrics
to uncover spatially coherent patterns of relationship between CC dam-
age and RRMS disability. The lack of a priori subdivisions on the bundle
did not preclude the discovery of associations between variables; in-
stead, it might have strengthened our results, leading us to the conclu-
sion that the macro- and micro-structural CC damage might be a very
sensitive marker of disease progression.
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